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Basic Investigations 
Astragaloside IV Regulates Expression of ATP-sensitive Potassium 
Channel Subunits after Ischemia-reperfusion in Rat Ventricular 
Cardiomyocytes 
HAN Xiang-hui 䶽৥ᰪ 1, LIU Ping ߬㧡 2, ZHANG Yi-yi ゴᗵ⼢ 1, ZHANG Na ᓴ࿰ 1, CHEN Fu-rong 䰜ᆠ㤷 1,  
and CAI Jue-feng 㫵⦣ዄ 1
Objective: Astragaloside IV (AsIV) is the major effective component extracted from the Chinese herb Astragalus 
membranaceus, which has been widely used to treat cardiovascular disease. Recent studies have shown that AsIV 
can potentially protect the heart from myocardial ischemic injury, but the mechanisms of action are unknown. 
ATP-sensitive potassium (KATP) channels are activated during ischemia and exert a compensatory protective effect 
on cardiomyocytes. We therefore examined the effects of AsIV on KATP channel currents and channel expression in 
isolated rat ventricular cardiomyocytes after ischemia-reperfusion injury.  
Methods: Forty Wistar rats were divided into five groups: control group, ischemia-reperfusion (IP) group, IP + 
glibenclamide group, IP + pinacidil group and IP + AsIV group. The ischemia-reperfusion injury model was 
established in enzymatically isolated ventricular cardiomyocytes by perfusion with calcium-free Tyrode solution for 
10 min, arrest for 30 min, and reperfusion for 45 min. The different drugs were applied for 10–15 min, and the 
KATP channel current (IKATP) was recorded with voltage-clamp mode by whole-cell patch-clamp technique. Protein 
and mRNA expression of the KATP channel subunits Kir6.1, Kir6.2, SUR2A and SUR2B was quantified using 
western blotting and real-time PCR.  
Results: The KATP current in IP group was significantly greater than that in control group (211.45±33.67 vs 
83.51±23.67 pA; P<0.01). Glibenclamide (10 μmol/L) blocked KATP currents, whereas both AsIV (1 mg/L) and the 
known channel opener pinacidil (50 μmol/L) significantly increased IKATP (P<0.05). Consistent with this, AsIV 
significantly up-regulated protein and mRNA expression of Kir6.1, Kir6.2, SUR2A, SUR2B (P<0.01 vs IP group). 
Conclusion: The protective effects of AsIV in ischemia-reperfusion injury may be related to the up-regulation of 
several KATP channel subunits and facilitation of KATP currents.  
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Ischemic heart disease (coronary heart disease) remains a 
major threat to human health. Ischemia-reperfusion may 
activate some ion channels that cannot open under 
normal physiological conditions. One such channel is the 
ATP-sensitive potassium (KATP) channel, which opens in 
response to a drop in cellular ATP levels and a decrease 
in the ATP/ADP ratio during ischemia. Channel 
activation facilitates potassium ion efflux, encouraging 
hyperpolarization and action potential repolarization. The 
resulting shortening of the action potential duration 
decreases the total influx of sodium and calcium. This 
inhibition of calcium influx alleviates overloading of 
intracellular calcium, weakens myocardial contraction 
force and reduces myocardial oxygen consumption. Thus, 
the opening of KATP channels plays an active role in 
protecting the heart against myocardial ischemia or 
hypoxia. 
Astragaloside IV (AsIV) is a major active component of 
the native Chinese herb Astragalus membranaceus, 
which has been widely used for the treatment of 
cardiovascular disease in China. Recent studies have 
shown that AsIV may play a potential role in protecting 
the heart from myocardial ischemia. The mechanism of 
action may involve antioxidative and nitric 
oxide-inducing properties, reduction of [Ca2+]i and 
 sarcoplasmic reticulum (SR) Ca2+ load, enhanced free 
radical removal, and decreased lipid peroxidation.1,2 
AsIV may also improve cardiac function in rats after 
ischemia-reperfusion injury,3 potentially due to 
prevention of [Ca2+]i overload through improvements in 
energy metabolism, scavenging of oxygen free radicals, 
and inhibition of free radical production in the ischemic 
myocardium. The aim of this study was to investigate the 
effects of AsIV on KATP channel currents and subunit 
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expression in rat ventricular myocytes after 
ischemia-reperfusion, to explore the mechanisms of 
AsIV action and provide experimental data for the 
development of new drugs.  
METHODS
Animals and Grouping 
Forty male Wistar rats (specific pathogen-free grade, 
provided by Shanghai Slac Laboratory Animal Company, 
Shanghai, China), weighing 200–300 g, were housed on 
a 12:12 light/dark cycle in the experimental animal 
center of Longhua Hospital Affiliated to Shanghai 
University of Traditional Chinese Medicine. Water and 
food were freely available. All experimental procedures 
were approved by the Animal Care Committee of 
Shanghai University of Traditional Chinese Medicine
and were in accordance with the principles outlined in 
the NIH Guide for the Care and Use of Laboratory 
Animals. The animals were randomly divided into five 
groups: control group, ischemia/reperfusion (IP) group, 
IP + glibenclamide (Gli) group, IP + pinacidil (Pina) 
group, and IP + AsIV group. 
Solution and Reagents 
Calcium-free Tyrode solution consisted of (in mmol/L) 
NaCl 137.0, KCl 5.0, MgSO4 1.2, NaH2PO4 0.5, glucose 
10.0, and HEPES 10.0 (pH was adjusted to 7.35-7.4 with 
NaOH). Tyrode solution consisted of (in mmol/L) NaCl 
137.0, CaCl2 1.8, KCl 5.0, MgSO4 1.2, NaH2PO4 0.5, 
glucose 10.0, and HEPES 10.0 (pH was adjusted to 
7.35-7.4 with NaOH). KB solution consisted of (in 
mmol/L) KOH 70.0, KCl 40.0, KH2PO4 20.0, L-glutamic 
acid 50.0, taurine 20.0, EGTA 0.5, HEPES 10.0, and 
glucose 10.0 (pH was adjusted to 7.35-7.4 with KOH). 
The extracellular solution used for whole-cell recording 
consisted of (in mmol/L) NaCl 137.0, CaCl2 1.2, KCl 5.0, 
MgSO4 1.2, NaH2PO4 0.5, glucose 10.0, and HEPES 
10.0 (pH was adjusted to 7.35-7.4 with NaOH). 
Primary antibodies: Kir6.1, Kir6.2, SUR2A, SUR2B, 
ȕ-actin and rabbit anti-mouse antibody were purchased 
from Wuhan Boster Biological Technology Co., Ltd. 
Wuhan, China. Secondary antibodies: goat anti-rabbit 
IgG HRP was produced by Rockland Immunochemicals 
Inc. (Gilbertsville, PA, USA). All antibodies were diluted 
1:2000 in PBS-T before analysis. The primers were 
synthesized by Shanghai Invitrogen Co., Ltd. (Shanghai, 
China). Pinacidil and glibenclamide were provided by 
Sigma-Aldrich Co. LLC (St Louis, MO, USA). 
Astragaloside IV was purchased from the National 
Institute for the Control of Pharmaceutical and 
Biological Products (Beijing, China). 
Preparation of the Ischemia-reperfusion Model in 
Ventricular Cardiomyocytes  
The rats were anesthetized by intraperitoneal injection of 
sodium pentobarbital (100 mg/kg body weight). The 
heart was excised in oxygen-saturated Tyrode solution at 
4 °C and was given retrograde perfusion in a 
non-recirculating Langendorff apparatus at constant 
pressure. All solutions were saturated with 95% O2/5% 
CO2 and the perfusion system was kept at a temperature 
of 37 °C with a flow velocity of 8–10 mL/min. The 
isolated heart was first infused for 10 min with 
calcium-free Tyrode solution and then subjected to a 20 
min global no-flow ischemia followed by a 45 min 
infusion of calcium-free Tyrode solution, and finally a 30 
min infusion of low-calcium Tyrode solution containing
0.5 g/L of collagenase (Sigma-Aldrich Co. LLC, St Louis, 
MO, USA) and 20 ȝmol/L Ca2+. The ventricle was cut 
into small pieces in KB solution and incubated for 10 
min. The dispersed cells were harvested by filtering with 
a 200-μm nylon mesh. The isolated ventricular myocytes 
from the second and third incubations were washed with 
Medium 199 containing 10% calf serum by low speed 
centrifugation before they were used for experiments. 
When the calcium concentration of the filtrate returned 
to 1.25 mmol/L at room temperature, 70–80% 
rod-shaped calcium-resistant myocardial cells retaining 
normal physiologic and metabolic functions were 
acquired. 
Whole-cell Patch-clamp Recordings  
KATP currents were recorded after 10–15 min of 
bath-application of the different drugs (glibenclamide 10 
μmol/L, pinacidil 50 μmol/L and astragaloside IV (1
mg/L). Recordings were made with standard whole-cell 
patch clamp techniques. Membrane currents were 
recorded and analyzed with an Axoclamp 200B amplifier 
in conjunction with the pClamp 6.0 software and the 
analog/digital interface (Axon Instruments, Union City, 
CA, USA). Voltage commands were delivered using 
Clampex 8.2 running on an IBM-compatible computer. 
Real-time Quantitative PCR Assays  
Total RNA was extracted from isolated ventricular 
cardiomyocytes treated with different drugs using a 
TRIzol kit, and subjected to one-step real-time 
quantitative PCR. The reverse transcription reaction was 
performed using 50 ng of total RNA that was reverse 
transcribed into cDNA using oligo (dT) primer, then 
amplified for 40 cycles using two oligonucleotide (ODN) 
primers (Kir 6.1: 5’-GAGTGA- 
ACTGTCGCACCAGA-3’ and 5’-CGATCACCAGAA- 
CTCAGCAA-3’; Kir6.2: 5’-CGATCACCAGAACTCA- 
GCAA-3’ and 5’-GATGGGGACAAAACGCTG-3’; 
SUR2A: 5’-GGAGCAATCCAGACCAAGAT-3’ and 
5’-AGCCAGCAGAATGATGACAG-3’; SUR2B: 5’- 
ACCTGCTCCAGCACAAGAAT-3’ and 5’-TCTCTT- 
CATCACAATGACCAGG-3’). Each PCR cycle was 
carried out for 30 s at 95 °C, 5 s at 95 °C and 30 s at 60 
°C. Serial dilutions of cDNA were used to construct the 
standard curve. Each data point was repeated three times. 
Quantitative values were obtained from the threshold 
PCR cycle number (Ct) at which the increase of signal 
was associated with an exponential growth of PCR 
product after it started to be detected. The relative 
expression levels of the target gene were calculated 
according to the equation ¨¨CT = (CTTarget - CTActin)Timex 
- (CTTarget - CTActin)Time 0. 
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Western Blotting Analysis  
Cells were rinsed twice with ice-cold PBS following 
treatment and scraped into ice-cold buffer containing 10 
mmol/L Tris-HCl (pH 7.5), 50 mmol/L NaCl, 50 mmol/L 
NaF, 10 mmol/L ethylenediaminetetraacetic acid (EDTA), 
1 mmol/L DTT, 1% Triton X-100, 0.1% SDS, 1% 
sodium deoxycholate, 1 mmol/L phenylmethylsulfonyl 
fluoride, 5 mmol/L leupeptin, and 5 mg/mL aprotinin. 
After lysis on ice for 30 min, the extracts were 
centrifuged for 15 min at 14000 g at 4 °C. The protein 
concentration of the supernatant was measured, and 20 
ȝg protein samples of cell lysate were mixed (1:1) with 
Laemmli sample buffer and incubated at 95 °C for 5 min. 
Proteins were subjected to sodium dodecyl sulfate 
(SDS)-polyacrylamide gel electrophoresis in 7.5% 
acrylamide gels. The separated proteins on the gels were 
transferred to polyvinylidene difluoride membranes, 
followed by Western blotting using specific antibodies. 
Membranes were blocked in 10 mmol/L Tris (pH 7.5), 
100 mmol/L NaCl, and 0.1% Tween 20 containing 5% 
non-fat dry milk, followed by incubation with primary 
antibody. Membranes were washed 3 times and 
incubated with the appropriate horseradish peroxidase 
conjugated secondary antibody for 2 h. The 
immunocomplexes were visualized by 
chemiluminescence with the Phototope western blot 
detection system. The images were digitalized using the 
Gel Imaging System (Alpha Innotech Corp, USA). Band
densitometry was carried out using NIH Image software. 
The expression levels of Kir6.1, Kir6.2, SUR2A, and 
SUR2B were expressed by ratios of these proteins to
ȕ-actin (internal standard).  
Statistical analysis  
All the data were expressed as mean±SD. Statistical 
analysis was carried out using Student’s t test and 
one-way ANOVA by SPSS12.0 software (SPSS Inc.). A 
value of P<0.05 was considered to be statistically 
significant. 
RESULTS 
Effect of Astragaloside IV on IKATP in Rat Ventricular 
Cardiomyocytes 
Under physiological conditions, KATP channels in 
ventricular cardiomyocytes are predominantly closed. 
Therefore, the membrane was clamped at -40 mV and 
subjected to a ramp from -100 to 80 mV to induce 
background currents. An outward current in the control 
group was 83.51±23.67 pA, whereas it was significantly 
increased in IP group (211.45±33.67 pA; P<0.01 vs the
control group). The outward current after 
ischemia-reperfusion was significantly blocked by 
glibenclamide (an antagonist of KATP channels), so this 
current was identified as IKATP. In the presence of 
pinacidil (an agonist of KATP channels), the outward 
current increased to 317.87±33.75 pA (P<0.01 vs IP 
group). Consistent with a KATP channel-mediated 
mechanism of AsIV, the IP + AsIV group showed a 
significantly increased outward current amplitude 
(406.22±23.28 pA; P<0.01 vs IP group) (Table 1). 
Figure 1 shows the outward current and voltage 
relationship. The current-voltage curve displayed an N 
shape, these voltage-dependent of currents were rising 
compared with the background currents, corresponding 
to the increased IKATP. 
Figure 1. IKATP current-voltage curves of ventricular 
cardiomyocytes. IP: ischemia/reperfusion; IP + Gli: IP + 
glibenclamide; IP + Pina: IP + pinacidil; IP + AsIV: IP + 
Astragaloside IV.
Effect of Astragaloside IV on the Expression of KATP 
Channel Subunit mRNA 
Quantitative real-time PCR demonstrated that the 
relative mRNA expression of the KATP channel subunits
SUR2A, Kir6.1, Kir6.2, SUR2B were significantly 
higher in the IP group than in the control group (P<0.01). 
Compared with the IP group, the subunit mRNA 
expression was significantly decreased in the IP + Gli 
group, and increased in the IP + AsIV and IP + Pin 
groups (Table 2). 
Table 1. Effect of astragaloside IV on KATP currents of rat ventricular cardiomyocytes at 0 mV
Group n KATP current amplitude (pA) 
Control  8   83.51±23.67¨¨ŸŸ
IP  8  211.45±33.67**ŸŸ
IP+Gli  8   129.68±30.92*¨¨ŸŸ
IP+Pina  8 317.87±33.75**¨¨
IP+ AsIV 8   406.22±23.28**¨¨ŸŸ
Notes: IP: ischemia/reperfusion; IP + Gli: IP + glibenclamide; IP + Pina: IP + pinacidil; IP + AsIV: IP + Astragaloside IV. Data are presented 
as mean ± SD. *P<0.05, **P<0.01 vs control group; ¨¨P<0.01 vs IP group; ŸŸP<0.01 vs IP+Pina group. 
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Table 2. Effect of astragaloside IV on expression of KATP channel subunit mRNA 
Group n Kir6.1 Kir6.2 SUR2A SUR2B 
Control  8 1.33±0.28¨Ÿ 1.28±0.30¨Ÿ 0.96±0.15¨Ÿ 1.09±0.23¨Ÿ
IP  8 3.15±0.58*Ÿ 2.61±0.36*Ÿ 1.80±0.27*Ÿ 2.10±0.41*Ÿ
IP+Gli  8 1.58±0.30¨Ÿ 1.18±0.18¨Ÿ 1.05±0.15¨Ÿ 1.08±0.20¨Ÿ
IP+Pina  8 5.64±0.82*¨ 3.80±0.55*¨ 3.10±0.54*¨ 3.48±0.71*¨
IP+ AsIV 8 6.61±0.95*¨Ÿ 5.18±0.73*¨Ÿ  4.05±0.65*¨Ÿ 4.30±0.64*¨Ÿ
Notes:IP: ischemia/reperfusion; IP + Gli: IP + glibenclamide; IP + Pina: IP + pinacidil; IP + AsIV: IP + Astragaloside IV. The data are 
presented as mean±SD. *P<0.01 vs control group; ¨P<0.01 vs IP group; ŸP<0.01 vs IP + Pina group. 
Effect of Astragaloside IV on KATP Channel Subunit 
Protein expression  
Western blotting showed that the SUR2A, Kir6.1 and 
Kir6.2 proteins were expressed in ventricular 
cardiomyocytes of the control group, while SUR2B was 
not detected. The expression of SUR2A, Kir6.1 and 
Kir6.2 proteins was increased in the IP group compared 
to the control group (P<0.05). In the IP + Gli group, the 
channel expression was inhibited, whereas both pinacidil 
and AsIV increased expression. AsIV caused a greater 
increase in KATP channel subunit expression than did 
pinacidil (P<0.05, Table 3, Figure 2). 
Figure 2. Expression of the KATP channel subunit 
proteins Kir6.1, Kir6.2, SUR2A, and SUR2B. IP: 
ischemia/reperfusion; IP + Gli: IP + glibenclamide; IP + 
Pina: IP + pinacidil; IP + AsIV: IP + Astragaloside IV. 
Table 3. Effect of astragaloside IV on the relative expression of KATP channel subunit protein 
Group n Kir6.1 Kir6.2 SUR2A SUR2B 
Control  8   0.33±0.17¨ŸŸ  0.05±0.03¨ŸŸ 0.12±0.13¨¨ŸŸ 0 
IP  8 1.11±0.071* 0.62±0.16* 0.75±0.12** 0.0006±0.0010 
IP+Gli  8   0.35±0.48¨ŸŸ 0.02±0.03¨ŸŸ  0.12±0.087¨¨ŸŸ 0 
IP+Pina  8 1.47±0.30** 1.11±0.13** 0.86±0.17** 1.75±0.82**¨¨
IP+ AsIV 8   2.34±0.52**¨¨Ÿ 1.85±0.98**¨¨Ÿ  1.25±0.091**¨¨Ÿ   4.85±1.14**¨¨ŸŸ
Notes: IP: ischemia/reperfusion; IP + Gli: IP+glibenclamide; IP + Pina: IP + pinacidil; IP + AsIV: IP + Astragaloside IV. Data are presented 
as mean ± SD. *P<0.05, **P<0.01 vs control group; ¨P<0.05, ¨¨P<0.01 vs IP group; ŸP<0.05,ŸŸP<0.01 vs IP + Pina group. 
DISCUSSION 
A decrease in cellular ATP during cardiac ischemia 
activates KATP channels that are silent under normal 
physiological conditions. As a result of the increased 
potassium current, the plateau phase of the action 
potential is shortened, which decreases total calcium 
influx. This in turn reduces calcium-related contraction 
and thereby energy consumption, thus providing a 
protective effect through negative feedback. During 
reperfusion, intracellular overloading of calcium triggers 
calcium-dependent phospholipid signaling, which leads 
to arachidonic acid (AA) metabolism. This causes 
production of oxygen free radicals, and the ischemic 
myocardium fails to take full advantage of oxygen, 
worsening the ischemic injury. 
KATP channels were initially discovered by Noma in 1983, 
who used patch-clamping of cardiomyocytes of guinea 
pigs.4,5 The channels were classified as sarcolemmal 
KATP channels and mitochondrial KATP channels, and 
these are thought to play important roles in myocardial 
ischemia/hypoxia, ischemic-reperfusion injury, and 
ischemic preconditioning.6-8 KATP channels can increase 
myocardial oxygen supply while decreasing oxygen 
consumption, thus improving cardiac function and 
myocardial energy metabolism, preserving the normal 
structure of the cells, regulating vascular tension, and 
changing ion distributions inside and outside the cardiac 
myocytes. These actions are shared by many endogenous 
vascular-active substances, such as adenosine, vasoactive 
intestinal peptide, and calcitonin gene related peptide, 
which are related to various signal molecules and signal 
transduction processes.9-11
Myocardial protection research has increasingly focused 
on KATP channels as a mediator of endogenous and 
exogenous vascular dilation and contraction.12,13
Representative potassium channel openers, including 
cromakalin, diazoxide and pinacidil, may facilitate 
potassium ion efflux to induce membrane 
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hyperpolarization and repolarization, counteracting the 
opening of voltage-dependent calcium channels. The 
effects are mediated by inhibition of the formation of 
inositol triphosphate, reductions in vascular contraction 
factors that induce cytoplasmic release of Ca2+, 
weakening of the sensitivity of organelles to Ca2+, and 
acceleration of the clearing of intracellular Ca2+ by 
Na+-Ca2+ exchangers to decrease intracellular free 
calcium.14-17 When KATP channels are open, cardiac 
myocytes can be protected by facilitation of ATP 
synthesis or inhibition of calcium overloading. Further, 
protection can be achieved by the promotion of oxygen 
free radical production during ischemia and inhibition of 
oxygen free radical production during reperfusion. KATP 
antagonists, including glibenclamide and cibenzoline, 
can block protective effect of KATP currents in the dog 
myocardium. In general, if an ion current was blocked by 
at least 100 μmol/L glibenclamide, we considered this to 
be mediated by the KATP channel.18 In this study, the 
ischemia-reperfusion injury was induced by 30 min of 
ischemia, followed by 45 min of reperfusion. Under 
these ischemic and hypoxic conditions, IKATP was 
significantly increased, and glibenclamide 10 μmol/L 
could block most of the KATP current. In contrast, 
pinacidil could significantly increase IKATP. 
Some studies have indicated that AsIV can improve 
post-ischemic cardiac function, prevent overloading of 
calcium by stimulating calcium extrusion through 
calcium pumps, and increase the levels of superoxide 
dismutase to reduce accumulation of free radicals during 
myocardial ischemia, thus preventing lipid peroxidation 
injury.19,20 The present study indicates that AsIV could 
also open KATP channels, with similar efficacy to 
pinacidil. 
The KATP channel is a tetramer containing the inward 
rectifier potassium channel protein Kir and the 
ATP-binding protein at a ratio of 1:1. The Kir protein 
forms an ion channel at the center of the tetramer, while 
the ATP-binding protein resides at the outskirts and 
determines the function of KATP. The main types of 
myocardial KATP channel subunits are SUR2A and Kir6.2, 
and vascular smooth muscle channels include SUR2B 
and Kir6.1.21-25 In this study, the expression of SUR2A, 
Kir6.1 and Kir6.2 were observed in the cardiomyocytes, 
but there was almost no expression of SUR2B. This 
result is consistent with previous reports.26,27 In the IP 
group, which showed increased KATP currents, the 
expression of the KATP channel subunits was significantly 
increased, providing further support for a role of these 
channels in the ischemic myocardium. Pinacidil 
increased the expression of channel subunits to protect 
cardiomyocytes after ischemia-reperfusion injury, while 
glibenclamide could block this effect. Meanwhile, AsIV 
also significantly increased the expression of the KATP
channel subunits, and the increase appeared to be larger 
than the change observed after pinacidil. We suggest that 
AsIV may facilitate the opening of KATP channels. 
In conclusion, AsIV is an opener of the KATP channel, 
and may thereby facilitate potassium ion efflux and 
induce membrane hyperpolarization and accelerate 
action potential repolarization, with resulting protective 
effects. The up-regulation of several protein subunits will 
also facilitate the opening of KATP channels, suggesting 
that AsIV is likely to have a cardioprotective effect after 
ischemia-reperfusion injury.  
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